Found: 8
Select item for more details and to access through your institution.
Bakuchiol inhibits lung cancer by modulating tumor microenvironment and the expression of PD‐L1.
- Published in:
- Journal of Biochemical & Molecular Toxicology, 2023, v. 37, n. 9, p. 1, doi. 10.1002/jbt.23401
- By:
- Publication type:
- Article
Cetuximab Maintenance Therapy in Patients with Unresectable Wild-Type RAS and BRAF Metastatic Colorectal Cancer: A Single-Institute Prospective Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Circ_0020123 Increases ZFX Expression to Facilitate Non-Small Cell Lung Cancer Progression by Sponging miR-142-3p.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 1687, doi. 10.2147/CMAR.S295595
- By:
- Publication type:
- Article
PRPS2‐mediated modulation of the antitumor immune response in lung cancer through CCL2‐mediated tumor‐associated macrophages and myeloid‐derived suppressor cells.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 23, p. 1739, doi. 10.1111/1759-7714.15398
- By:
- Publication type:
- Article
Intermediary Metabolite Precursor Dimethyl-2-Ketoglutarate Stabilizes Hypoxia-Inducible Factor-1α by Inhibiting Prolyl-4-Hydroxylase PHD2.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0113865
- By:
- Publication type:
- Article
SNRPD1/E/F/G Serve as Potential Prognostic Biomarkers in Lung Adenocarcinoma.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.813285
- By:
- Publication type:
- Article
Molecular landscape and therapeutic alterations in Asian soft‐tissue sarcoma patients.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 21, p. 4070, doi. 10.1002/cam4.4725
- By:
- Publication type:
- Article
RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article